Cargando…
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
BACKGROUND: Prostate cancer (PrCa) is the second most prevalent malignancy in men worldwide. Observational studies have linked the use of low-density lipoprotein cholesterol (LDL-c) lowering therapies with reduced risk of PrCa, which may potentially be attributable to confounding factors. In this st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810198/ https://www.ncbi.nlm.nih.gov/pubmed/36595504 http://dx.doi.org/10.1371/journal.pmed.1003988 |